TrialSignal
Clinical trial intelligence report
Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT02444325-Jul 28, 2026
NCT ID
NCT02444325
Status
COMPLETED
Phase
Pilot Study (Not classified in traditional phases)
Sponsor
Washington University School of Medicine
Executive brief
Investment-Ready Snapshot
This pilot randomized control trial, sponsored by Washington University School of Medicine, explores the efficacy of group prenatal care for women with diabetes, specifically targeting self-care activities. The study's outcomes could have significant implications for maternal and neonatal health, particularly in the context of diabetes management during pregnancy. If successful, this approach may lead to broader adoption of group prenatal care models, potentially impacting healthcare delivery and reimbursement strategies in maternal health. The market for diabetes management in pregnancy is substantial, with increasing awareness and demand for innovative care models. Competitively, this trial positions the sponsor as a leader in maternal diabetes care, potentially influencing future guidelines and practices.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT02444325
Indication
Pregnancy
Modality
behavioral intervention
Target
Group prenatal care intervention aimed at improving self-care activities in women with diabetes.
Intervention
Group prenatal care
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.